|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:bfsLayer
|
4
|
|
gptkbp:bfsParent
|
gptkb:Vicks
gptkb:Claritin-D
|
|
gptkbp:approves
|
gptkb:2005
gptkb:FDA
|
|
gptkbp:availability
|
Prescription-free in some regions
|
|
gptkbp:brand
|
Allegra
|
|
gptkbp:clinical_trial
|
Safety profile assessment
Efficacy in allergic rhinitis
|
|
gptkbp:contains
|
gptkb:Pseudoephedrine
Fexofenadine
|
|
gptkbp:contraindication
|
Severe coronary artery disease
Severe hypertension
|
|
gptkbp:current_use
|
Common cold
Sinusitis
Hay fever
Chronic rhinitis
|
|
gptkbp:dosage_form
|
Oral
|
|
gptkbp:formulation
|
Extended-release
|
|
gptkbp:has_ability
|
120 mg Pseudoephedrine
60 mg Fexofenadine
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Allegra-D
|
|
gptkbp:indication
|
Seasonal allergic rhinitis
Nasal congestion
|
|
gptkbp:ingredients
|
gptkb:Pseudoephedrine_sulfate
Fexofenadine hydrochloride
|
|
gptkbp:interacts_with
|
gptkb:Monoamine_oxidase_inhibitors
Other antihistamines
|
|
gptkbp:is_available_on
|
gptkb:tablet
|
|
gptkbp:is_used_for
|
Allergy relief
|
|
gptkbp:manager
|
Oral
|
|
gptkbp:manufacturer
|
gptkb:Sanofi
|
|
gptkbp:marketed_as
|
gptkb:Australia
gptkb:United_Kingdom
gptkb:United_States
gptkb:Native_American_tribe
|
|
gptkbp:packaging
|
Blister pack
|
|
gptkbp:population
|
Adults
Children over 12
|
|
gptkbp:previous_name
|
Fexofenadine and Pseudoephedrine
|
|
gptkbp:replaced_by
|
Not applicable
|
|
gptkbp:requires
|
Over-the-counter
|
|
gptkbp:research
|
Long-term use effects
Comparative efficacy study
Adverse effects monitoring
Drug interaction analysis
|
|
gptkbp:safety_features
|
Category C
|
|
gptkbp:scholarships
|
Avoid alcohol
Consult doctor if pregnant
Do not exceed recommended dose
May cause dizziness
|
|
gptkbp:shelf_life
|
2 years
|
|
gptkbp:side_effect
|
gptkb:Nausea
Headache
Drowsiness
Dry mouth
|
|
gptkbp:storage
|
Room temperature
|